ICU Medical, Inc. to Present at the 29th Annual ROTH Conference
March 07 2017 - 7:00AM
ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development,
manufacture and sale of innovative medical devices used in infusion
therapy, oncology and critical care applications, today announced
that Company management will present at the 29th Annual ROTH
Conference, held on March 12-15, 2017 at the Ritz-Carlton Hotel in
Laguna Niguel, CA.
ICU Medical’s presentation will take place on Monday, March 13
at 9:00 AM Pacific Time.
The presentation will be webcast live and can be accessed by
going to the Company's website at http://www.icumed.com, clicking
on the Investors tab and clicking on the Event Calendar tab. The
webcast will also be available by replay.
About ICU Medical, Inc.
ICU Medical, Inc. (Nasdaq:ICUI) is one of the world’s leading
pure-play infusion therapy companies with global operations and a
wide-ranging product portfolio that includes IV solutions, IV smart
pumps, dedicated and non-dedicated IV sets and needlefree
connectors, along with pain management and safety software
technology designed to help meet clinical, safety and workflow
goals. In addition, the company manufactures automated pharmacy IV
compounding systems with workflow technology, closed systems
transfer devices for hazardous IV drugs, and cardiac monitoring
systems to optimize patient fluid levels. ICU Medical is
headquartered in San Clemente, California. On February 3, 2017, ICU
Medical completed the acquisition of the Hospira Infusion Systems
business from Pfizer. More information about ICU Medical, Inc. can
be found at www.icumed.com.
Contact:
ICU Medical, Inc.
Scott Lamb, Chief Financial Officer
(949) 366-2183
ICR, Inc.
John Mills, Partner
(646) 277-1254
ICU Medical (NASDAQ:ICUI)
Historical Stock Chart
From Mar 2024 to Apr 2024
ICU Medical (NASDAQ:ICUI)
Historical Stock Chart
From Apr 2023 to Apr 2024